Synapse - Weinberg Fellows

Results (2820)

Real world chart review of blinatumomab to treat patients with high disease burden of relapsed or refractory B-cell precursor acute lymphoblastic leukemia

Meeting Abstract

King, A. C.; Bolanos, R.; Velasco, K.; Tu, H.; Zaman, F.; Geyer, M. B.; Park, J. H.
Blood (2019)

Fulltext@MSK | Save

Acute leukemia with lineage infidelity: Mixed phenotype AML exhibits a distinct immunophenotype with clinical features overlapping mixed phenotype acute leukemia

Meeting Abstract

Kresch, M. P.; Xiao, W.; Menghrajani, K.; Famulare, C.; Patel, M. A.; Baik, J.; Roshal, M.; Levine, R. L.; Tallman, M. S.; Glass, J. L.
Blood (2019)

Fulltext@MSK | Save

Younger patients with newly diagnosed FLT3-mutant AML treated with crenolanib plus chemotherapy achieve adequate free crenolanib levels and durable remissions

Meeting Abstract

Goldberg, A. D.; Coombs, C. C.; Wang, E. S.; Walter, R. B.; Karanes, C.; Vigil, C. E.; Messahel, B.; Stone, R. M.; Collins, R. H.
Blood (2019)

Fulltext@MSK | Save

Dual driver mutant BCR-ABL1-negative myeloid neoplasms: Multicenter clinicopathologic and genomic analysis

Meeting Abstract

Epstein-Peterson, Z. D.; Tripodi, J.; Arcila, M. E.; Sen, F.; Najfeld, V.; Mascarenhas, J.; Hoffman, R.; Rampal, R. K.
Blood (2019)

Fulltext@MSK | Save

Contemporary outcomes in HTLV-1-associated adult T-cell leukemia/lymphoma: Single-institution experience

Meeting Abstract

Epstein-Peterson, Z. D.; Ghione, P.; Moskowitz, A. J.; Dahi, P. B.; Dogan, A.; Kumar, A.; Matasar, M. J.; Noy, A.; Perales, M. A.; Ponce, D. M.; more...
Blood (2019)

Fulltext@MSK | Save

De novo myelodysplastic syndromes in patients 20-50 years old characterized by frequent mutations in TP53 and transcription-related genes

Meeting Abstract

Epstein-Peterson, Z. D.; Spitzer, B.; McCarter, J.; McGovern, E.; Levine, R. L.; Tallman, M. S.
Blood (2019)

Fulltext@MSK | Save

Pegaspargase can safely be administered in adults age 40 and older with acute lymphoblastic leukemia

Meeting Abstract

Daley, R. J.; Rajeeve, S.; Kabel, C. C.; Pappacena, J. J.; Stump, S. E.; Lavery, J. A.; Tallman, M. S.; Geyer, M. B.; Park, J. H.
Blood (2019)

Fulltext@MSK | Save

Targeted sequencing predicts the development of myeloid malignancies and clinical outcome in patients with unexplained cytopenia

Meeting Abstract

Cargo, C.; Bolton, K.; Beinortas, T.; Glover, P.; Short, M.; Smith, A.; Taylor, J.; Evans, P. A. S.; Papaemmanuil, E.; Crouch, S.
Blood (2019)

Fulltext@MSK | Save

Central nervous system prophylaxis with high-dose intravenous methotrexate or intrathecal chemotherapy in patients with diffuse large B-cell lymphoma and high-risk of CNS relapse treated in the rituximab era

Meeting Abstract

Bobillo, S.; Joffe, E.; Seshan, V.; Noy, A.; Horwitz, S. M.; Palomba, M. L.; Matasar, M. J.; Straus, D. J.; Hamlin, P. A.; Batlevi, C. L.; more...
Blood (2019)

Fulltext@MSK | Save

Combined venetoclax and hypomethylating agent (HMA) therapy induces high response rates in patients with myelodysplastic syndrome including patients previously failing HMA

Meeting Abstract

Ball, B. J.; Famulare, C.; Stein, E. M.; Tallman, M. S.; Gill, S. I.; Manning, B. M.; Koprivnikar, J.; McCloskey, J.; Testi, R.; Al Ali, N.; more...
Blood (2019)

Fulltext@MSK | Save